|
C18ORF21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.648400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.116400E-01 |
| Normal-vs-Stage2 |
3.362600E-01 |
| Normal-vs-Stage3 |
7.711400E-01 |
| Normal-vs-Stage4 |
7.916200E-01 |
| Stage1-vs-Stage2 |
5.446600E-01 |
| Stage1-vs-Stage3 |
6.771400E-01 |
| Stage1-vs-Stage4 |
3.494800E-01 |
| Stage2-vs-Stage3 |
4.309600E-01 |
| Stage2-vs-Stage4 |
2.432400E-01 |
| Stage3-vs-Stage4 |
5.828200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.159000E-01 |
| Normal-vs-AfricanAmerican |
3.064200E-01 |
| Normal-vs-Asian |
6.954500E-02 |
| Caucasian-vs-AfricanAmerican |
1.876050E-01 |
| Caucasian-vs-Asian |
6.571700E-02 |
| AfricanAmerican-vs-Asian |
2.315600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.524800E-01 |
| Normal-vs-Female |
8.298600E-01 |
| Male-vs-Female |
7.130300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.309400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.076200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.757400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.265000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.706800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.757400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.287600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.283800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.258400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.921200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.822010E-01 |
| Classical-VS-Follicular |
2.782400E-01 |
| Classical-VS-Other |
7.804000E-01 |
| Classical-VS-Normal |
5.468600E-01 |
| Tall-VS-Follicular |
4.510300E-02 |
| Tall-VS-Other |
3.062600E-01 |
| Tall-VS-Normal |
4.247600E-01 |
| Follicular-VS-Other |
8.994400E-01 |
| Follicular-VS-Normal |
1.767800E-01 |
| Other-VS-Normal |
5.796600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.918040E-01 |
| Normal-vs-N1 |
7.155800E-01 |
| N0-vs-N1 |
4.820600E-01 |
|
|
